Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Janssen Sciences Ireland UC .
Filed returns
28
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Janssen Sciences Ireland UC | Health | Engagement with the Departments of Health and Enterprise regarding the national life science strategy (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Health | Meeting with Department of Health (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Economic Development and Industry | Engagements with Irish policymakers on national life sciences policy (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | Health | Engagement with the Department of Health on the Life Sciences Strategy (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Introductions to new Ministers outlining industry priorities (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2025 | Janssen Sciences Ireland UC | Economic Development and Industry | Interaction with Secretary General of the Department of Health (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Health | Engagement with Oireachtas members re new development funding for medicines due for reimbursement in 2025. (Matters involving public funds) | 3 | On lobbying.ie |
| Sep–Dec 2024 | Janssen Sciences Ireland UC | Health | Communication with Robert Watt re reimbursement process reform (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | Janssen Sciences Ireland UC | Budgetary matters | Engagement with Government Ministers about Budget 2024 (Matters involving public funds) | 9 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Discussion at Health Summit on proposed reforms to medicines reimbursement (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Sharing information on life sciences sector in Ireland & on EU pharmaceutical package (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Discussion at IPHA Conference on Proposed Reforms to Medicines Reimbursement (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Janssen Sciences Ireland UC | Health | Sharing Invite to discussion series on 'Ireland & the European Health Union Series: What will it mean for rare disease'' (Public policy or programme) | 15 | On lobbying.ie |
| Sep–Dec 2022 | Janssen Sciences Ireland UC | Health | Sharing Invite to discussion series on 'Ireland & the European Health Union Series: Opportunities to Improve Irish Healthcare' (Public policy or programme) | 23 | On lobbying.ie |
| Jan–Apr 2022 | Janssen Sciences Ireland UC | Health | Invite to webinar series on the 'Future of Value Based Healthcare in Ireland', RCSI Dublin (Public policy or programme) | 9 | On lobbying.ie |
| Sep–Dec 2021 | Janssen Sciences Ireland UC | Health | Sharing information of patient research on clinical depression (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2021 | Janssen Sciences Ireland UC | Health | Sharing information on European Beating Cancer Plan and impact on Ireland (Public policy or programme) | 10 | On lobbying.ie |
| May–Aug 2021 | Janssen Sciences Ireland UC | Health | Sharing copy of a new report on Cell and Gene therapies (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2021 | Janssen Sciences Ireland UC | Health | Invitation to Discuss Patient Research on Mental Illness (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2021 | Janssen Sciences Ireland UC | Health | Sharing progress and information on Janssen COVID19 Vaccine clinical development, supply updates and public communication (Public policy or programme) | 11 | On lobbying.ie |
| May–Aug 2020 | Janssen Sciences Ireland UC | Health | Sharing information on backlog of approved cancer medicines and consequences for treatment of patients (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2020 | Janssen Sciences Ireland UC | Health | Sharing update on the timeline for the development of JnJ vaccine for COVID-19 and about some of JnJ’s local efforts to assist the health service during pandemic (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2020 | Janssen Sciences Ireland UC | Economic Development and Industry | Briefing on business continuity plans during COVID-19 pandemic and progress on vaccine development as well as offering to support health service with expertise and capabilities (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2020 | Janssen Sciences Ireland UC | Health | Sharing information on backlog of approved cancer medicines and consequences for treatment of patients (Public policy or programme) | 9 | On lobbying.ie |
| May–Aug 2019 | Janssen Sciences Ireland UC | Health | Invite to visit Janssen garden ‘Grounded’ at Bloom in the Park festival (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2019 | Janssen Sciences Ireland UC | Health | Outcomes based contracting for medicines (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2018 | Janssen Sciences Ireland UC | Health | Outcomes based contracting for medicines (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2018 | Janssen Sciences Ireland UC | Health | Neuroscience Disease Areas (Public policy or programme) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 23 | 82.1% | |
| Economic Development and Industry | 4 | 14.3% | |
| Budgetary matters | 1 | 3.6% |